This compound is a derivative of the antiviral nucleoside analog ganciclovir, modified with a valine amino acid residue protected by a carboxybenzyl (Cbz) group. It is primarily used as an intermediate in the synthesis of nucleotide analog antiviral agents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 194154-40-0
SCHEMBL14125267
pharmaceutical intermediate
Benzyloxycarbonyl valacyclovir
pharmaceutical intermediate
1,2-DI-TERT-BUTYL (2S,4S)-4-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE
pharmaceutical intermediate
4-Acetylamino-2-(diethylamino)anisole
pharmaceutical intermediate
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione
pharmaceutical intermediate
(E)-N'-(4-AMINO-2-CYANOPHENYL)-N,N-DIMETHYLFORMIMIDAMIDE
pharmaceutical intermediate
[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate
UMWCZUCRFYVVAW-LYKKTTPLSA-N
CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)NC(=O)OCC3=CC=CC=C3